Sig Group Ag · SIX:SIGN
Sig — Q1 2024 Earnings Presentation
13 slides from Sig's earnings presentation, Apr 30, 2024
Slide 1: Q1 2024 Trading Statement
Q1 2024 Trading Statement SIG Group AG Samuel Sigrist, CEO Anne Erkens, CFO April 30, 2024
Slide 2: Disclaimer and cautionary statement
Disclaimer and cautionary statement The information contained in this presentation is not for use within any Neither SIG nor any of its directors, officers, employees, agents, affiliates or These alternative non-IFRS measures are presented as we believe that they country or jurisdiction or by any pe
Slide 3: Q1 2024 business summary
Q1 2024 business summary Stable volume, initial signs of recovery, progress on future production footprint and continued innovation Revenue Strategic Aseptic filling Financing performance investments to technology support future innovation growth Volume growth in Transfer of Shanghai Speed up kits l
Slide 4: Q1 2024 financial summary
Q1 2024 financial summary Performance reflects expected phasing throughout the year Revenue Adjusted EBITDA Adjusted net Free cashflow €722 million income (1.0)% €155 €40 €(101) reported million million million (Q1 2023: €175 m) (Q1 2023: €65 m) (Q1 2023: €(95) m) 0.0% Adjusted EBITDA margin Net cap
Slide 5: Q1 2024 regional summary: Europe and India, Middle East and Africa
Q1 2024 regional summary Europe and India, Middle East and Africa Europe Revenue growth at constant currency and constant resin 6.2% (€ million) Q1 2024 Strong aseptic carton volume growth Revenue 251 Continue to win new filler contracts in liquid dairy and food Revenue growth 5.8% (constant c
Slide 6: Q1 2024 regional summary: Asia Pacific and Americas
Q1 2024 regional summary Asia Pacific and Americas Asia Pacific Revenue growth at constant currency and constant resin 8.1% (€ million) Q1 2024 China reflects strong recovery in aseptic and chilled carton volumes following COVID-19 impact in Q1 2023. Both aseptic and chilled Revenue 185 packagin
Slide 7: Q1 2024 adjusted EBITDA bridge
Q1 2024 adjusted EBITDA bridge Margin recovery expected from Q2 2024 FX headwinds compared to prior year 24.0%(1) 21.5%(1) Top line impacted by unfavorable mix Raw material benefit from lower hedged prices for polymers and aluminum -10 -6 6 1 -7 -4 Production includes lower freight rates 175
Slide 8: EBITDA reconciliation
EBITDA reconciliation Three months Three months ended March ended March € million 31, 2024 31, 2023 €19.1 million(1) of adjustments relate to EBITDA 134 166 restructuring and impairment charges Adjustments to EBITDA: for the relocation of the chilled carton plant Unrealized (gain)/loss on operatin
Slide 9: Net income reconciliation
Net income reconciliation Three months Three months ended March ended March € million 31, 2024 31, 2023 Profit for the period (7) 23 Non-cash foreign exchange impact of non-functional currency loans and realized foreign 1 2 exchange impact due to refinancing Amortization of transaction costs 1 1 Net
Slide 10: Free cash flow
Free cash flow Reflects Q1 seasonality Three months Three months Free cash flow broadly inline with prior ended March ended March year period € million 31, 2024 31, 2023 Net cash from operating activities 8 30 Lease liability payment reflects increase Acquisition of property, plant and in right
Slide 11: Leverage and financing
Leverage and financing Net leverage reflects seasonality but remains below 3x € million Mar 31, 2024 Dec 31, 2023 Year-on-year improvement in net Gross debt 2,548 2,458 leverage (March 31, 2023: 3.1x) Cash 266 281 Group expects to reduce net leverage to around 2.5x by year-end 2024 Net debt 2,28
Slide 12: 2024 guidance confirmed
2024 guidance confirmed H1 reflects seasonality volume recovery accelerating in H2 4–6% Revenue growth Low end of the range Resin escalator for bag-in- (constant currency) box & spouted pouch not included in guidance 25-26% Guidance subject to end- Adjusted EBITDA Within lower half of margin the
Slide 13: Thank you!
Thank you! www.sig.biz